| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 364.25M | — |
| Operating expense | — | — |
| Net income | -57.94M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MDGL returned +24.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -11.3% |
| 1 year | +24.6% |
| 5 years | +524.5% |
| 10 years | +4377.8% |
| All-time high | $596.98 (Nov 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in MDGL would be worth today ›No. Madrigal Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Madrigal Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol MDGL.
Madrigal Pharmaceuticals, Inc. is part of the Healthcare sector.
Madrigal Pharmaceuticals, Inc. has a market cap of 11.94B USD, based on the latest quote.
